BioSpace News Archive

The global pharmacy market size was estimated at USD 1,009.5 billion in 2020, and is predicted to reach around USD 1,522.1 billion by 2030, growing at a CAGR of 4.8% from 2022 to 2030.

According to Report, the Clinical Trials Support Services market size is estimated to surpass around US$ 45.2 billion by 2030 and it is expected to grow at a CAGR of 10.3% from 2021 to 2030.

Roivant Sciences will participate in four upcoming healthcare investor conferences.

Albireo Pharma, Inc. (Nasdaq: ALBO), a rare liver disease company developing novel bile acid modulators, today announced participation in the H.C. Wainwright Global Life Science Conference May 23-26, 2022.

Geron Corporation reported that it has granted non-statutory stock options to purchase an aggregate of 327,400 shares of Geron common stock as inducements to newly hired employees in connection with commencement of employment with the Company.

4D pharma plc, a pharmaceutical company leading the development of Live Biotherapeutic products, a novel class of drug derived from the microbiome, announced that Duncan Peyton, Chief Executive Officer of 4D pharma, will present at the H.C. Wainwright Global Investment Conference.

The signed agreement establishes beachhead to broadly market and distribute Tru Niagen® to Mainland China’s aging population ChromaDex Corp. a global bioscience company dedicated to healthy aging, announced it has entered into an agreement to establish a joint venture through its wholly owned subsidiary ChromaDex Asia Limited.

CytRx Corporation announced that its Board of Directors declared a dividend of one one-thousandth of a share of newly designated Series D Preferred Stock, par value $0.01 per share, for each outstanding share of the Company’s common stock held of record as of 5:00 pm Eastern Time on May 20, 2022.

Edesa Biotech, Inc. announced that Par Nijhawan, MD, Chief Executive Officer, will present virtually at the H.C. Wainwright Global Investment Conference being held May 23-26, 2022.

The global Clinical Laboratory Service market size is estimated to be worth around US$ 288.10 billion by 2030 and it is anticipated to grow at a registered CAGR of 4.10% from 2021 to 2030.